Advertisement

More articles from Priority Brief

  • USP22 Is a Deubiquitinase of CD274
    Xing Huang, Qi Zhang, Yu Lou, Junli Wang, Xinyu Zhao, Lin Wang, Xiaozhen Zhang, Shanshan Li, Yulan Zhao, Qi Chen, Tingbo Liang, Xueli Bai
    Cancer Immunology Research Oct 2019, 7 (10) 1580-1590; DOI: 10.1158/2326-6066.CIR-18-0910
  • Interferon-γ for Cold Tumors
    Shihong Zhang, Karan Kohli, R. Graeme Black, Lu Yao, Sydney M. Spadinger, Qianchuan He, Venu G. Pillarisetty, Lee D. Cranmer, Brian A. Van Tine, Cassian Yee, Robert H. Pierce, Stanley R. Riddell, Robin L. Jones, Seth M. Pollack
    Cancer Immunology Research Aug 2019, 7 (8) 1237-1243; DOI: 10.1158/2326-6066.CIR-18-0940
  • TIGIT and PD-1, and Their Cognate Ligands, in NHL
    Sarah E. Josefsson, Klaus Beiske, Yngvild N. Blaker, Mette S. Førsund, Harald Holte, Bjørn Østenstad, Eva Kimby, Hakan Köksal, Sébastien Wälchli, Baoyan Bai, Erlend B. Smeland, Ronald Levy, Arne Kolstad, Kanutte Huse, June H. Myklebust
    Cancer Immunology Research Mar 2019, 7 (3) 355-362; DOI: 10.1158/2326-6066.CIR-18-0351
  • Impact of Infectious ERVs on Mouse Cancer Models
    Eleonora Ottina, Prisca Levy, Urszula Eksmond, Julia Merkenschlager, George R. Young, Juliette Roels, Jonathan P. Stoye, Thomas Tüting, Dinis P. Calado, George Kassiotis
    Cancer Immunology Research Nov 2018, 6 (11) 1292-1300; DOI: 10.1158/2326-6066.CIR-18-0038
  • NetH2pan: A Multi-Allele Predictor for Murine MHCI Epitopes
    Christa I. DeVette, Massimo Andreatta, Wilfried Bardet, Steven J. Cate, Vanessa I. Jurtz, Kenneth W. Jackson, Alana L. Welm, Morten Nielsen, William H. Hildebrand
    Cancer Immunology Research Jun 2018, 6 (6) 636-644; DOI: 10.1158/2326-6066.CIR-17-0298
  • CAR-T Cells Target Human GUCY2C+ Colorectal Tumors
    Michael S. Magee, Tara S. Abraham, Trevor R. Baybutt, John C. Flickinger, Natalie A. Ridge, Glen P. Marszalowicz, Priyanka Prajapati, Adam R. Hersperger, Scott A. Waldman, Adam E. Snook
    Cancer Immunology Research May 2018, 6 (5) 509-516; DOI: 10.1158/2326-6066.CIR-16-0362
  • CXCL12 Inhibition Synergizes with PD-1 Checkpoint Inhibition
    Dirk Zboralski, Kai Hoehlig, Dirk Eulberg, Anna Frömming, Axel Vater
    Cancer Immunology Research Nov 2017, 5 (11) 950-956; DOI: 10.1158/2326-6066.CIR-16-0303
  • Breast Cancer Neoantigens Can Induce Antitumor Immunity
    Xiuli Zhang, Samuel Kim, Jasreet Hundal, John M. Herndon, Shunqiang Li, Allegra A. Petti, Savas D. Soysal, Lijin Li, Mike D. McLellan, Jeremy Hoog, Tina Primeau, Nancy Myers, Tammi L. Vickery, Mark Sturmoski, Ian S. Hagemann, Chris A. Miller, Matthew J. Ellis, Elaine R. Mardis, Ted Hansen, Timothy P. Fleming, S. Peter Goedegebuure, William E. Gillanders
    Cancer Immunology Research Jul 2017, 5 (7) 516-523; DOI: 10.1158/2326-6066.CIR-16-0264
  • Acquired Resistance to Anti–PD-1 Therapy
    Daniel Y. Wang, Zeynep Eroglu, Alpaslan Ozgun, Paul D. Leger, Shilin Zhao, Fei Ye, Jason J. Luke, Richard W. Joseph, Rizwan Haq, Patrick A. Ott, F. Stephen Hodi, Jeffrey A. Sosman, Douglas B. Johnson, Elizabeth I. Buchbinder
    Cancer Immunology Research May 2017, 5 (5) 357-362; DOI: 10.1158/2326-6066.CIR-16-0287
  • Agonistic 4-1BB Antibody Controls Spontaneous B Lymphoma
    Sara J. McKee, Brianna L. Doff, Megan S.F. Soon, Stephen R. Mattarollo
    Cancer Immunology Research Mar 2017, 5 (3) 191-197; DOI: 10.1158/2326-6066.CIR-16-0249

Pages